Molecular pathology of fatal familial insomnia

Piero Parch, Robert B. Petersen, Shu G. Chen, L. Autilio-Gambetti, Sabina Capellari, Lucia Monari, Pietro Cortelli, Pasquale Montagna, Elio Lugaresi, Pierluigi Gambetti

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Fatal familial insomnia (FFI) is linked to a mutation at codon 178 of the prion protein gene, coupled with the methionine codon at position 129, the site of a methionine/valine polymorphism. The D178N mutation coupled with the 129 valine codon is linked to a subtype of Creutzfeldt-Jakob disease (CJD178) with a different phenotype. Two protease resistant fragments of the pathogenic PrP (PrP(res)), which differ in molecular mass, are associated with FFI and CJD178, respectively, suggesting that the two PrP(res) have different conformations and hence they produce different disease phenotypes. FFI transmission experiments, which show that the endogenous PrP(res) recovered in affected syngenic mice specifically replicates the molecular mass of the FFI PrP(res) inoculated and is associated with a phenotype distinct from that of the CJD178 inoculated mice, support this idea. The second distinctive feature of the FFI PrP(res) is the underrepresentation of the unglycosylated PrP(res) form. Cell models indicate that the underrepresentation of this PrP(res) form results from the PrP dysmetabolism caused by the D178N mutation and not from the preferential conversion of the glycosylated forms. Codon 129 on the normal allele further modifies the FFI phenotype determining patient subpopulations of 129 homozygotes and heterozygotes: disease duration is generally shorter, insomnia more severe and histopathology more restricted to the thalamus in the homozygotes than in the heterozygotes. The allelic origin of PrP(res) fails to explain this finding since in both cases FFI PrP(res) is expressed only by the mutant allele. Despite remarkable advances, many issues remain unsolved precluding full understanding of the FFI pathogenesis.

Original languageEnglish
Pages (from-to)539-548
Number of pages10
JournalBrain Pathology
Volume8
Issue number3
Publication statusPublished - 1998

Fingerprint

Fatal Familial Insomnia
PrPSc Proteins
Molecular Pathology
Codon
Phenotype
Homozygote
Valine
Heterozygote
Methionine
Mutation
Alleles
Creutzfeldt-Jakob Syndrome
Sleep Initiation and Maintenance Disorders
Thalamus
Peptide Hydrolases

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pathology and Forensic Medicine

Cite this

Parch, P., Petersen, R. B., Chen, S. G., Autilio-Gambetti, L., Capellari, S., Monari, L., ... Gambetti, P. (1998). Molecular pathology of fatal familial insomnia. Brain Pathology, 8(3), 539-548.

Molecular pathology of fatal familial insomnia. / Parch, Piero; Petersen, Robert B.; Chen, Shu G.; Autilio-Gambetti, L.; Capellari, Sabina; Monari, Lucia; Cortelli, Pietro; Montagna, Pasquale; Lugaresi, Elio; Gambetti, Pierluigi.

In: Brain Pathology, Vol. 8, No. 3, 1998, p. 539-548.

Research output: Contribution to journalArticle

Parch, P, Petersen, RB, Chen, SG, Autilio-Gambetti, L, Capellari, S, Monari, L, Cortelli, P, Montagna, P, Lugaresi, E & Gambetti, P 1998, 'Molecular pathology of fatal familial insomnia', Brain Pathology, vol. 8, no. 3, pp. 539-548.
Parch P, Petersen RB, Chen SG, Autilio-Gambetti L, Capellari S, Monari L et al. Molecular pathology of fatal familial insomnia. Brain Pathology. 1998;8(3):539-548.
Parch, Piero ; Petersen, Robert B. ; Chen, Shu G. ; Autilio-Gambetti, L. ; Capellari, Sabina ; Monari, Lucia ; Cortelli, Pietro ; Montagna, Pasquale ; Lugaresi, Elio ; Gambetti, Pierluigi. / Molecular pathology of fatal familial insomnia. In: Brain Pathology. 1998 ; Vol. 8, No. 3. pp. 539-548.
@article{e2ad407fc1824f88a4a7c24dc38c4930,
title = "Molecular pathology of fatal familial insomnia",
abstract = "Fatal familial insomnia (FFI) is linked to a mutation at codon 178 of the prion protein gene, coupled with the methionine codon at position 129, the site of a methionine/valine polymorphism. The D178N mutation coupled with the 129 valine codon is linked to a subtype of Creutzfeldt-Jakob disease (CJD178) with a different phenotype. Two protease resistant fragments of the pathogenic PrP (PrP(res)), which differ in molecular mass, are associated with FFI and CJD178, respectively, suggesting that the two PrP(res) have different conformations and hence they produce different disease phenotypes. FFI transmission experiments, which show that the endogenous PrP(res) recovered in affected syngenic mice specifically replicates the molecular mass of the FFI PrP(res) inoculated and is associated with a phenotype distinct from that of the CJD178 inoculated mice, support this idea. The second distinctive feature of the FFI PrP(res) is the underrepresentation of the unglycosylated PrP(res) form. Cell models indicate that the underrepresentation of this PrP(res) form results from the PrP dysmetabolism caused by the D178N mutation and not from the preferential conversion of the glycosylated forms. Codon 129 on the normal allele further modifies the FFI phenotype determining patient subpopulations of 129 homozygotes and heterozygotes: disease duration is generally shorter, insomnia more severe and histopathology more restricted to the thalamus in the homozygotes than in the heterozygotes. The allelic origin of PrP(res) fails to explain this finding since in both cases FFI PrP(res) is expressed only by the mutant allele. Despite remarkable advances, many issues remain unsolved precluding full understanding of the FFI pathogenesis.",
author = "Piero Parch and Petersen, {Robert B.} and Chen, {Shu G.} and L. Autilio-Gambetti and Sabina Capellari and Lucia Monari and Pietro Cortelli and Pasquale Montagna and Elio Lugaresi and Pierluigi Gambetti",
year = "1998",
language = "English",
volume = "8",
pages = "539--548",
journal = "Brain Pathology",
issn = "1015-6305",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Molecular pathology of fatal familial insomnia

AU - Parch, Piero

AU - Petersen, Robert B.

AU - Chen, Shu G.

AU - Autilio-Gambetti, L.

AU - Capellari, Sabina

AU - Monari, Lucia

AU - Cortelli, Pietro

AU - Montagna, Pasquale

AU - Lugaresi, Elio

AU - Gambetti, Pierluigi

PY - 1998

Y1 - 1998

N2 - Fatal familial insomnia (FFI) is linked to a mutation at codon 178 of the prion protein gene, coupled with the methionine codon at position 129, the site of a methionine/valine polymorphism. The D178N mutation coupled with the 129 valine codon is linked to a subtype of Creutzfeldt-Jakob disease (CJD178) with a different phenotype. Two protease resistant fragments of the pathogenic PrP (PrP(res)), which differ in molecular mass, are associated with FFI and CJD178, respectively, suggesting that the two PrP(res) have different conformations and hence they produce different disease phenotypes. FFI transmission experiments, which show that the endogenous PrP(res) recovered in affected syngenic mice specifically replicates the molecular mass of the FFI PrP(res) inoculated and is associated with a phenotype distinct from that of the CJD178 inoculated mice, support this idea. The second distinctive feature of the FFI PrP(res) is the underrepresentation of the unglycosylated PrP(res) form. Cell models indicate that the underrepresentation of this PrP(res) form results from the PrP dysmetabolism caused by the D178N mutation and not from the preferential conversion of the glycosylated forms. Codon 129 on the normal allele further modifies the FFI phenotype determining patient subpopulations of 129 homozygotes and heterozygotes: disease duration is generally shorter, insomnia more severe and histopathology more restricted to the thalamus in the homozygotes than in the heterozygotes. The allelic origin of PrP(res) fails to explain this finding since in both cases FFI PrP(res) is expressed only by the mutant allele. Despite remarkable advances, many issues remain unsolved precluding full understanding of the FFI pathogenesis.

AB - Fatal familial insomnia (FFI) is linked to a mutation at codon 178 of the prion protein gene, coupled with the methionine codon at position 129, the site of a methionine/valine polymorphism. The D178N mutation coupled with the 129 valine codon is linked to a subtype of Creutzfeldt-Jakob disease (CJD178) with a different phenotype. Two protease resistant fragments of the pathogenic PrP (PrP(res)), which differ in molecular mass, are associated with FFI and CJD178, respectively, suggesting that the two PrP(res) have different conformations and hence they produce different disease phenotypes. FFI transmission experiments, which show that the endogenous PrP(res) recovered in affected syngenic mice specifically replicates the molecular mass of the FFI PrP(res) inoculated and is associated with a phenotype distinct from that of the CJD178 inoculated mice, support this idea. The second distinctive feature of the FFI PrP(res) is the underrepresentation of the unglycosylated PrP(res) form. Cell models indicate that the underrepresentation of this PrP(res) form results from the PrP dysmetabolism caused by the D178N mutation and not from the preferential conversion of the glycosylated forms. Codon 129 on the normal allele further modifies the FFI phenotype determining patient subpopulations of 129 homozygotes and heterozygotes: disease duration is generally shorter, insomnia more severe and histopathology more restricted to the thalamus in the homozygotes than in the heterozygotes. The allelic origin of PrP(res) fails to explain this finding since in both cases FFI PrP(res) is expressed only by the mutant allele. Despite remarkable advances, many issues remain unsolved precluding full understanding of the FFI pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=7144253121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7144253121&partnerID=8YFLogxK

M3 - Article

C2 - 9669705

AN - SCOPUS:7144253121

VL - 8

SP - 539

EP - 548

JO - Brain Pathology

JF - Brain Pathology

SN - 1015-6305

IS - 3

ER -